Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preventing vascular access dysfunction: which policy to follow.

Anatole Besarab1

  • 1Division of Nephrology, Department of Medicine, University of West Virginia School of Medicine, Morgantown, WV, USA. abesarab@pol.net

Blood Purification
|January 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemodialysis Vascular Access: A Historical Perspective on Access Promotion, Barriers, and Lessons for the Future.

Kidney medicine·2024
Same author

Association of risk stratification score with dialysis vascular access stenosis.

The journal of vascular access·2022
Same author

Development and validation of a risk score to prioritize patients for evaluation of access stenosis.

Seminars in dialysis·2021
Same author

Roxadustat for CKD-related Anemia in Non-dialysis Patients.

Kidney international reports·2021
Same author

Roxadustat for anemia in patients with end-stage renal disease incident to dialysis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2021
Same author

The problem with transferrin saturation as an indicator of iron 'sufficiency' in chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2020

The US aims to improve hemodialysis vascular access by increasing autologous arteriovenous fistulas (AVFs) and enhancing access surveillance, thereby reducing catheter use. Policies promoting timely AVF creation are most impactful.

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Public Health Policy

Background:

  • Current US Clinical Performance Measures focus on hemodialysis vascular access.
  • Key measures include increasing autologous arteriovenous fistulas (AVFs) and reducing catheter use.
  • Surveillance and preemptive correction of access dysfunction are critical.

Purpose of the Study:

  • To outline strategies and resources for improving hemodialysis vascular access.
  • To emphasize the importance of increasing AVF creation rates.
  • To advocate for policies promoting AVF construction and access surveillance.

Main Methods:

  • Analysis of existing Clinical Performance Measures in the USA.
  • Discussion of strategies to meet performance targets for AVFs and reduce catheter use.

Related Experiment Videos

  • Emphasis on the role of preemptive monitoring and surveillance.

    • Main Results:

    • Policies promoting AVF creation and access surveillance are crucial for reducing catheter use.
    • Increasing AVF rates in incident and prevalent hemodialysis patients is a primary goal.
    • Timely AVF creation offers the most significant impact on vascular access outcomes.

    Conclusions:

    • A team approach is essential for successful implementation of vascular access policies.
    • Policies should prioritize timely AVF creation and robust access surveillance.
    • These initiatives are expected to reduce reliance on catheters in hemodialysis patients.